Use of Patented Products for International Humanitarian Purposes Regulations, SOR/2005-143

Section 7

Cite as Use of Patented Products for International Humanitarian Purposes Regulations, SOR/2005-143, s. 7 · current to July 24, 2025 · regulation last amended June 25, 2018

Statute Watch

Get an alert when a bill in Parliament would change this section, and every time it moves.

The text

For the purpose of section 21.06 of the Act, the website of the holder of an authorization shall disclose the following information: (a) if the pharmaceutical product named in the application is a drug as defined in section 2 of the Food and Drugs Act, the name of the pharmaceutical product as set out in Schedule 1 to the Act and, if applicable, the strength, dosage form and route of administration of the pharmaceutical product, or if the pharmaceutical product is a medical device, the name of the medical device; (b) the name of the country or WTO Member named in the application to which the pharmaceutical product is to be exported; (c) if the country or WTO Member referred to in paragraph (b) is not itself the purchaser of the pharmaceutical product, the name of the person or entity — other than a governmental person or entity — referred to in paragraph 21.04(2)(f) of the Act, to which the product is to be sold, together with their postal address; (d) the quantity of the pharmaceutical product that, under section 21.04 of the Act, has been authorized to be manufactured for export to the country or WTO Member referred to in paragraph (b); (e) the distinguishing features of the pharmaceutical product — including its colour if applicable — and of its label and packaging, as required by regulations made under the Food and Drugs Act; (f) the name and postal address of the shipping agent and any other party that, to the knowledge of the holder of the authorization, will be handling the pharmaceutical product while it is in transit from Canada to the country or WTO Member referred to in paragraph (b); (g) if the consignee in the importing country or WTO Member is a person or entity other than the country or WTO Member referred to in paragraph (b), or the person or entity referred to in paragraph (c), as the case may be, the name and postal address of the consignee; (h) the quantity of the pharmaceutical product contained in each shipment; (i) the export tracking number issued by the Minister of Health in respect of each shipment; and (j) the number of the bill of lading for each shipment.
Read the Use of Patented Products for International Humanitarian Purposes Regulations on the Justice Laws Website ↗

Made under Patent Act, R.S.C. 1985, c. P-4.

Bills in Parliament that would change this section 0

No bill we hold would amend or repeal this section.